Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Merck
Boehringer Ingelheim
McKesson
Harvard Business School
Dow
Teva
Novartis
Cerilliant
Fuji

Generated: February 18, 2018

DrugPatentWatch Database Preview

IBUPRIN Drug Profile

« Back to Dashboard

Which patents cover Ibuprin, and when can generic versions of Ibuprin launch?

Ibuprin is a drug marketed by Pliva and is included in one NDA.

The generic ingredient in IBUPRIN is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and sixty-one suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

US Patents and Regulatory Information for IBUPRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pliva IBUPRIN ibuprofen TABLET;ORAL 071773-001 Jul 16, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Fuji
Daiichi Sankyo
McKesson
Covington
Boehringer Ingelheim
Cantor Fitzgerald
AstraZeneca
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot